Terry L. Murdock is vice president and head of the Oncology Center of Excellence at Quintiles. He focuses on developing insights and innovations that help improve the probability of success of Quintiles’ oncology customer development projects and programs. As part of a team, he provides customers with alternative and innovative design aimed to improve the efficiency of development of oncology assets.
Terry has 20 years of work experience as a successful senior executive in the medical research industry, specializing in oncology, multiple sclerosis and other autoimmune diseases. He is experienced at establishing operational excellence within culturally diverse environments with a track record executing operational, clinical and commercial plans. Prior to joining Quintiles, Terry held senior positions focused on clinical drug development at Ergomed, Genzyme/Sanofi, ILEX Oncology and US Oncology.
Terry earned his M.S. in biology and a B.S. in science in microbiology from the University of Texas at Arlington. He is a registered microbiologist for the American Society of Clinical Pathology and a registered medical technologist for American Medical Technologists.